Stocklytics Platform
Asset logo for symbol PHAT
Phathom Pharmaceuticals
Asset logo for symbol PHAT



AI Deep-Learning Forecast (PHAT)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Phathom Pharmaceuticals (PHAT) Stocklytics Forecast

The stock price of Phathom Pharmaceuticals Inc (PHAT) has been the subject of much speculation and interest among investors. Many are eager to predict the future movement of this pharmaceutical company's stock and determine whether it is a good investment opportunity. While it is impossible to perfectly predict stock prices, there are tools and techniques available that can provide insights into potential future trends. AI-powered price prediction models have gained popularity in recent years due to their ability to analyze vast amounts of data and identify patterns that might escape human observers. Machine learning algorithms can be trained on historical stock price data, as well as various other factors, such as company fundamentals, market conditions, and industry trends.

These AI and machine learning models can generate forecasts and predictions for future stock prices, including that of Phathom Pharmaceuticals Inc (PHAT). These predictions are based on patterns and correlations observed in past data and can provide investors with a rough estimation of where the stock price might be heading. However, it is essential to note that such predictions are not guarantees, and there are several factors that can influence the future stock price, such as regulatory changes, competition, market conditions, and company performance.

add Phathom Pharmaceuticals  to watchlist

Keep an eye on Phathom Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

What is the analyst price prediction for Phathom Pharmaceuticals (PHAT) stock?

Analysts have set a target price of $25.39 for Phathom Pharmaceuticals (PHAT), based on forecasts from 23 analysts. The predicted price range extends from a high of $48 to a low of $9. This represents a potential increase of up to 338.56% and a decrease of -17.77% from the current price of $10.94. These forecasts are as of 2019 Nov 20.

What are the analyst ratings for Phathom Pharmaceuticals (PHAT) stock?

Currently, there are no analyst ratings available for Phathom Pharmaceuticals (PHAT), possibly due to insufficient coverage or recent updates.

What is the AI price prediction for Phathom Pharmaceuticals (PHAT) stock?

At present, there is no AI or machine-learning-based price prediction available for Phathom Pharmaceuticals (PHAT) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.


Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level